Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
about
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesRisk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.Treatment of relapsed and refractory Hodgkin Lymphoma.A Review of Autologous Stem Cell Transplantation in Lymphoma.Hodgkin Lymphoma in Adults
P2860
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@en
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@nl
type
label
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@en
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@nl
prefLabel
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@en
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@nl
P2093
P2860
P1433
P1476
Single or tandem autologous st ...... the LYSA/SFGM-TC study group.
@en
P2093
Ambroise Marçais
Bénédicte Deau-Fischer
Catherine Sebban
David Ghez
David Sibon
Franck Morschhauser
Gilles Salles
Jehan Dupuis
Matthieu Resche-Rigon
Pauline Brice
P2860
P304
P356
10.3324/HAEMATOL.2015.136408
P577
2015-12-31T00:00:00Z